Nanotheranostics, the sister journal of Theranostics, is a multidisciplinary and fully open access journal. Nanotheranostics publishes innovative and original basic, translational and clinical research reflecting the fields of nanomedicine, nanoimaging, drug and gene delivery, nanoelectronic biosensors, and related areas.
Regular features include high quality research articles, reviews or mini-reviews, rapid communication of preliminary data on innovative research, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical studies or ethical issues of nanomedicine are also welcome. Timely reviews that provide updates on current applications and issues in nanomedicine and translational aspects of nanotheranostics and other topics are particularly welcome and will be given high priority.
Nanotheranostics employs a rigorous peer-review system, but also strives for rapid review turnaround times and is based on the same streamlined submission platform as Theranostics.
Research Paper Distinct Internalization, Acoustic Behavior and Stress Responses to Nanobubbles in Pancreatic Cancer Cells Full text PDF
Research Paper A Compact Non-Ionizing RF Bioelectronic Sensor for Translational Phantom-Based Detection of Tumor-Like Dielectric Changes in Bone Full text PDF PubMed PMC
Review Nanotechnology-Driven Ultrasound/Photoacoustic Theranostics for Real-Time Imaging and Therapeutics Full text PDF PubMed PMC
Research Paper Big data analytics for CLEC5A dynamics based on single cell genomics and proteomics reveal its diverse functions in human diseases Full text PDF PubMed PMC
Research Paper Small extracellular vesicles reflect senescence progression in human bone marrow-derived mesenchymal stem cells during hollow fiber bioreactor culture Full text PDF PubMed PMC
Review Next-Generation Anticancer Peptides: Engineering, Nanotheranostics and Clinical Translation Full text PDF PubMed PMC
Editor-in-Chief:
Jonathan F. Lovell
SUNY Empire Innovation Professor
Department of Biomedical Engineering
University at Buffalo, State University of New York
Nanotheranostics has been selected by The Literature Selection Technical Review Committee (LSTRC) for inclusion in MEDLINE, the prestigious index of U.S. National Library of Medicine.
- Full texts of articles in PubMed Central and Europe PMC. Abstracts in PubMed.
- Indexed in the Biological Abstracts and BIOSIS Previews of Web of Science.
- (For NIH-funded researchers) Save time by submitting your paper to us - this journal is in full compliance with NIH Public Access Requirement.
Impact Score: 8.25, h-Index: 38, SJR: 1.2, based on information from Resurchify, 2025.
Cancer Nanomedicine: Special Issue in Honour of Prof. Joao Conde’s Contribution to Nanomedicine. Guest Editors: Prof. Zaver M. Bhujwalla, Prof. Lucia Gemma Delogu, Dr. Bárbara B. Mendes.
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, characterized by an extremely low survival rate once diagnosed. Over 90% of cases harbor activating KRAS mutations, which are associated with metabolic reprogramming and altered endocytic activity. New treatment modalities are urgently needed. Phospholipid-shelled, gas-filled nanobubbles (NBs) are promising ultrasound (US) contrast agents and drug delivery vehicles, with potential ...